No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
AAN240517P7500
- 0.15
- 0.000.00%
15min DelayClose May 10 10:17 ET
0.00High0.00Low
0.15Open0.15Pre Close0 Volume51 Open Interest7.50Strike Price0.00Turnover66.85%IV-3.16%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier3DDays to Expiry0.15Time Value100Contract SizeAmericanOptions Type-0.4110Delta0.7988Gamma50.60Leverage Ratio-0.0301Theta-0.0003Rho-20.80Eff Leverage0.0028Vega
Intraday
- 5D
- 1D
News
It Looks Like The Aaron's Company, Inc.'s (NYSE:AAN) CEO May Expect Their Salary To Be Put Under The Microscope
Key Insights Aaron's Company will host its Annual General Meeting on 15th of May Total pay for CEO Douglas Lindsay includes US$850.0k salary The overall pay is 91% above the industry average Aa
Aaron's Price Target Cut to $8.00/Share From $9.00 by Truist Securities
Aaron's Price Target Cut to $8.00/Share From $9.00 by Truist Securities
Aaron's Is Maintained at Hold by Truist Securities
Aaron's Is Maintained at Hold by Truist Securities
Truist Securities Maintains Hold on Aarons, Lowers Price Target to $8
Truist Securities analyst Scot Ciccarelli maintains Aarons with a Hold and lowers the price target from $9 to $8.
Aarons Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/08/2024 14.29% Truist Securities $9 → $8 Maintains Hold 03/08/2024 0% TD Cowen → $7 Initiates Coverage
Express News | Aaron's Company Inc : Truist Securities Cuts Target Price to $8.00 From $9.00
Comments
Despite Aaron's Company's limited growth expectations, investors are still willing to pay for exposure to the stock. However, the company's current P/S ratio may be at risk of declining unless there is a positive change in its revenue outlook.
The Aaron's Company, Inc.'s (NYSE:AAN) Price Is Out Of Tune With Revenues
$Aarons Holdings Co Inc(AAN.US$ $Aclarion(ACON.US$ $Bed Bath & Beyond Inc(BBBY.US$ $EyePoint Pharmaceuticals(EYPT.US$ $First Republic Bank(FRC.US$ $JPMorgan(JPM.US$ $Moderna(MRNA.US$ $Netcapital(NCPL.US$ $Microsoft(MSFT.US$ $NextPlat(NXPL.US$ $Roku Inc(ROKU.US$ $Tenaya Therapeutics(TNYA.US$ $United Parcel Service(UPS.US$ $Virios Therapeutics(VIRI.US$
6
2
Gapping up
In reaction to earnings/guidance:
• $Comtech Telecommunications(CMTL.US$ +2.1%, $Micron Technology(MU.US$+1.5%
Other news:
• $Amylyx Pharmaceuticals(AMLX.US$ +9.3% (receives FDA approval for Relyvrio)
• $Ready Capital(RC.US$ +4.9% (increases share buyback authorization by $25 mln)
• $Blue Apron(APRN.US$ +2.5% (CFO to resign)
• $Fluor(FLR.US$ +2.3% (US Dept of Energy extends Fluor-led Savannah River contract)
• $Immuneering(IMRX.US$ +1.6% (re...
In reaction to earnings/guidance:
• $Comtech Telecommunications(CMTL.US$ +2.1%, $Micron Technology(MU.US$+1.5%
Other news:
• $Amylyx Pharmaceuticals(AMLX.US$ +9.3% (receives FDA approval for Relyvrio)
• $Ready Capital(RC.US$ +4.9% (increases share buyback authorization by $25 mln)
• $Blue Apron(APRN.US$ +2.5% (CFO to resign)
• $Fluor(FLR.US$ +2.3% (US Dept of Energy extends Fluor-led Savannah River contract)
• $Immuneering(IMRX.US$ +1.6% (re...
10
Gainers:
In reaction to earnings/guidance:
$Liberty Energy(LBRT.US$ +11.6%, $F5 Inc(FFIV.US$ +6.9%, $Encore Wire(WIRE.US$ + 5.6%, $Archer Daniels Midland(ADM.US$ +5.5%, $Bank of N.T Butterfield & Son(NTB.US$ +5%, $Albany International(AIN.US$ +5%, $3M(MMM.US$ +4.0%,
Other news:
$Shell Midstream(SHLX.US$ +10% (Shell USA to acquire all units in SHLX held by public at $15.85/unit total value $1.96 bln)
$BridgeBio Pharma(BBIO.US$...
In reaction to earnings/guidance:
$Liberty Energy(LBRT.US$ +11.6%, $F5 Inc(FFIV.US$ +6.9%, $Encore Wire(WIRE.US$ + 5.6%, $Archer Daniels Midland(ADM.US$ +5.5%, $Bank of N.T Butterfield & Son(NTB.US$ +5%, $Albany International(AIN.US$ +5%, $3M(MMM.US$ +4.0%,
Other news:
$Shell Midstream(SHLX.US$ +10% (Shell USA to acquire all units in SHLX held by public at $15.85/unit total value $1.96 bln)
$BridgeBio Pharma(BBIO.US$...
13
3
Read more